An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma (vol 94, pg 90, 2011)

Miura Katsuhiro<sup>*</sup>; Takei Kazuhiro; Kobayashi Sumiko; Kiso Satomi; Hirabayashi Yukio; Hojo Atsuko; Kodaira Hitomi; Yagi Mai; Kurita Daisuke; Kobayashi Yujin; Tanaka Toshitake; Iriyama Noriyoshi; Hatta Yoshihiro; Kura Yoshimasa; Yamazaki Tetsuo; Sawada Umihiko; Takeuchi Jin

doi:10.1007/s12185-011-0896-6

免费注册

赞收藏引用

科研之友

微信

新浪微博

Facebook

分享链接

An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma (vol 94, pg 90, 2011)

作者：Miura Katsuhiro^*; Takei Kazuhiro; Kobayashi Sumiko; Kiso Satomi; Hirabayashi Yukio; Hojo Atsuko; Kodaira Hitomi; Yagi Mai; Kurita Daisuke; Kobayashi Yujin; Tanaka Toshitake; Iriyama Noriyoshi; Hatta Yoshihiro; Kura Yoshimasa; Yamazaki Tetsuo; Sawada Umihiko; Takeuchi Jin

来源：International Journal of Hematology, 2011, 94(2): 218-218.

DOI：10.1007/s12185-011-0896-6